Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 7, 2006 - Issue 16
Submit an article Journal homepage
67
Views
7
CrossRef citations to date
0
Altmetric
Drug Evaluation

Tolcapone in the management of Parkinson’s disease

Julie Leegwater-Kim Fellow in Movement Disorders, Columbia University Medical Center, Department of Neurology, Division of Movement Disorders, 710 W. 168th Street, New York, NY 10032, USA
&
Cheryl Waters Albert B and Judith L Glickman Professor, Columbia University Medical Center, Department of Neurology, Division of Movement Disorders, 710 W. 168th Street, New York, NY 10032, USA. [email protected]
Pages 2263-2270 | Published online: 24 Oct 2006

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Daniel D Truong. (2009) Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson’s disease. Clinical Interventions in Aging 4, pages 109-113.
Read now
Angelo Antonini, Giovanni Abbruzzese, Paolo Barone, Ubaldo Bonuccelli, Leonardo Lopiano, Marco Onofrj, Mario Zappia & Aldo Quattrone. (2008) COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features. Neuropsychiatric Disease and Treatment 4:1, pages 1-9.
Read now
Shimon Lecht, Simon Haroutiunian, Amnon Hoffman & Philip Lazarovici. (2007) Rasagiline – a novel MAO B inhibitor in Parkinson’s disease therapy. Therapeutics and Clinical Risk Management 3:3, pages 467-474.
Read now

Articles from other publishers (4)

Subramanian Thangaleela, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, Subramanian Mariappan, Subramanian Rashmi, Thiwanya Choeisoongnern, Phakkharawat Sittiprapaporn & Chaiyavat Chaiyasut. (2023) Neurological Insights into Sleep Disorders in Parkinson’s Disease. Brain Sciences 13:8, pages 1202.
Crossref
Rachel Fremont, Masood Manoochehri, Nicole M. Armstrong, Venkata S. Mattay, Jose A. Apud, Mary C. Tierney, D.P. Devanand, Yunglin Gazes, Christian Habeck, Eric M. Wassermann, Jordan Grafman & Edward D. Huey. (2020) Tolcapone Treatment for Cognitive and Behavioral Symptoms in Behavioral Variant Frontotemporal Dementia: A Placebo-Controlled Crossover Study. Journal of Alzheimer's Disease 75:4, pages 1391-1403.
Crossref
Marios G. Krokidis. (2019) Identification of biomarkers associated with Parkinson’s disease by gene expression profiling studies and bioinformatics analysis. AIMS Neuroscience 6:4, pages 333-345.
Crossref
Kapil Sethi, Stewart Factor & Ray Watts. (2014) Quality of Life in Parkinson's Disease Patients Following Adjunctive Tolcapone Therapy: Results of an Open-Label, Multicenter, Community-Based Trial . CNS Spectrums 15:1, pages 27-32.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.